Cavadex™ Phase 1 trial results

APRIL 2019

CAVADEX REDUCES PLAQUE WITHIN 4 WEEKS

CAVADEX was administered to our first patient in our Melbourne clinic in April 2019 and within 4 weeks the plaque was reduced.

CAVADEX circulates around the cardiovascular system removing built up cholesterol and plaque resulting in significant plaque reduction.

CAVADEX is absorbed via intravenous application or as an enema only. If taken orally it is destroyed in the gut and has no effect.